Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
PHAR
↓ PDF (Pro)Pharming Group N.V. ADS each representing 10 ordinary shares
HealthcareBiotechnologyNetherlandsNASDAQ
$16.74
+3.52%today
MKT CAP
$1.2B
-6.4% · 1Y
Earnings History
+12.0%
+148.0%
+122.2%
+460.0%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$16.74
Low
$23.40
Analyst Mean
$34.60
High
$41.00
4 analystsNone
Full Financials
Trailing P/E300.0x
Forward P/E32.7x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ+9.5%
5y Revenue CAGR+22.3%
5y Earnings CAGR-40.7%
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership0.0%
Institutional Ownership0.2%
Short % of Float0.01%
Days to Cover0.4d
1 Week-0.8%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| Silverberg Bernstein Capital Management LLC | institution | 0.06% | $0.00B | -11.47% | 2026-03-31 |
| NewEdge Advisors, LLC | institution | 0.04% | $0.00B | +11310.28% | 2025-12-31 |
| Millennium Management Llc | institution | 0.03% | $0.00B | +100.00% | 2025-12-31 |
| Citadel Advisors Llc | institution | 0.03% | $0.00B | +100.00% | 2025-12-31 |
| Smartharvest Portfolios, LLC | institution | 0.02% | $0.00B | -14.90% | 2026-03-31 |
| Morgan Stanley | institution | 0.01% | $0.00B | +76.81% | 2025-12-31 |
| Eversource Wealth Advisors, Llc | institution | 0.00% | $0.00B | -34.35% | 2025-12-31 |
| Global Retirement Partners, LLC | institution | 0.00% | $0.00B | +256.52% | 2025-12-31 |
| BNP Paribas Financial Markets | institution | 0.00% | $0.00B | +700.00% | 2025-12-31 |
| Nalls Sherbakoff Group, Llc | institution | 0.00% | $0.00B | +0.00% | 2025-12-31 |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | fund | 0.00% | $0.00B | +0.00% | 2026-02-28 |
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for PHAR.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.